Clinical Trial Update: Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) [Phase 3]

View source ↗

Summary

Phase 3 immunogenicity and safety study assessing concomitant administration of ProQuad and Infanrix Hexa has been completed and results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Hepatitis B
• Measles
• Mumps
• Pertussis
• Rubella
• Tetanus
• Varicella

Drugs mentioned

• Infanrix Hexa (DTPa-HBV-IPV/Hib)
• ProQuad (Measles, Mumps, Rubella and Varicella live attenuated vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Varicella, Measles | Phase 3 | Status: COMPLETED | Results posted: 2018-03-19